clinical trial Archives - Page 3 of 6 -

US biotech BioSig Technologies’ subsidiary ViralClear has been cleared by the FDA to start a phase 2 trial

Biosig cleared to test merimepodib plus remdesivir in COVID-19

https://pharmaphorum.com/news/biosig-cleared-to-test-merimepodib-plus-remdesivir-in-covid-19/

News/ News/ R&D

Genfit’s NASH hopes are dashed by phase 3 trial fail

Phil Taylor clinical trial, Genfit, NASH 0 Comment

Genfit has seen almost two-thirds of the value wiped off its shares after its much-anticipated pivotal trial of

Genfit’s NASH hopes are dashed by phase 3 trial fail

https://pharmaphorum.com/news/genfits-nash-hopes-are-dashed-by-phase-3-trial-fail/

News/ News/ R&D

Ferring’s gut microbiome drug clears phase 3 trial in C. diff

Phil Taylor C. diff infections, clinical trial, Ferring, gastroenterology, infectious disease, microbiome, Rebiotix 0 Comment

Ferring Pharma has reported what it says is the first positive phase 3 trial of a microbiome therapy

Ferring’s gut microbiome drug clears phase 3 trial in C. diff

https://pharmaphorum.com/news/ferrings-gut-microbiome-drug-clears-phase-3-trial-in-c-diff/

Digital/ News/ News

AiCure launches “digital biomarker” app for clinical trials

Phil Taylor adherence, AiCure, clinical trial, digital 0 Comment

Artificial intelligence company AiCure has launched a digital tool that detects subtle changes in a patient’s condition that

AiCure launches “digital biomarker” app for clinical trials

https://pharmaphorum.com/news/aicure-launches-digital-biomarker-app-for-clinical-trials/

News/ News/ News/ Oncology/ R&D

Immuno-oncology latecomer GSK shows off PD-1 drug data

Phil Taylor clinical trial, dostarlimab, GlaxoSmithKline, immuno-oncology, Oncology, PD-1 0 Comment

GlaxoSmithKline has new data showing that its cancer immunotherapy dostarlimab works as a second-line treatment for women with

Immuno-oncology latecomer GSK shows off PD-1 drug data

https://pharmaphorum.com/news/immuno-oncology-latecomer-gsk-shows-off-pd-1-drug-data/

News/ News/ R&D

Pfizer, BioNTech aim to start German COVID-19 vaccine trial this month

Phil Taylor BioNTech, clinical trial, coronavirus, coronavirus vaccine, Pfizer 0 Comment

Pfizer and BioNTech are in pole position to start the first human trial of a COVID-19 vaccine in

Pfizer, BioNTech aim to start German COVID-19 vaccine trial this month

https://pharmaphorum.com/news/pfizer-biontech-aim-to-start-german-covid-19-vaccine-trial-this-month/

News/ News/ News/ Patients/ R&D

Oxford Uni coronavirus vaccine trial could begin this week

Phil Taylor clinical trial, coronavirus, coronavirus vaccine, Oxford University, vaccine 0 Comment

University of Oxford researchers are due to start dosing healthy volunteers in a clinical trial of their coronavirus

Oxford Uni coronavirus vaccine trial could begin this week

https://pharmaphorum.com/news/uk-coronavirus-vaccine-trial-could-begin-this-week/

News/ News/ R&D

Gilead slides as second Chinese trial of remdesivir is stopped

Phil Taylor clinical trial, coronavirus, Gilead Sciences, infectious disease, remdesivir 0 Comment

Two investigator-led phase 3 trials of Gilead Sciences’ coronavirus candidate remdesivir have now been halted because they weren’t

Gilead slides as second Chinese trial of remdesivir is stopped

https://pharmaphorum.com/news/gilead-slides-as-two-chinese-trials-of-remdesivir-are-stopped/

News/ News/ News/ Patients/ R&D

AZ, Lilly join efforts to develop drugs for COVID-19

Phil Taylor AstraZeneca, Calquence, clinical trial, coronavirus, Eli Lilly, Olumiant 0 Comment

AstraZeneca and Eli Lilly have joined the ranks of drugmakers around the world trying to repurpose existing drugs

AZ, Lilly join efforts to develop drugs for COVID-19

https://pharmaphorum.com/news/az-lilly-join-efforts-to-develop-drugs-for-covid-19/

Trending

clinical trial

Login